WHO ICTRP trial
A study in healthy volunteers to assess the different formulations (recipes) of…
ISRCTN12868063 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN12868063 |
|---|---|
| Public title | A study in healthy volunteers to assess the different formulations (recipes) of the drug product (alectinib) |
| Scientific title | Single part, open-label, phase 1 study designed to evaluate the relative bioavailability of oral alectinib formulations compared with an oral reference alectinib capsule, in healthy subjects |
| Primary sponsor | Chugai Pharmaceutical Co., Ltd. |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I |
| Countries | United Kingdom;England |
| Conditions | Cancer Cancer |
| Interventions | Participants will receive a single oral 600 mg dose of one of the following across six study periods: 1. Reference alectinib capsule in the fasted state 2. Alectinib powder for oral suspension in the fed or fasted state 3. Alectinib oral… |
| Registration date | Jul 10, 2022 |
| Target size | 26 |
| Secondary IDs | 2021-003298-78;Nil known;JP43290, IRAS 301567 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: